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Abstract
A series of extensively drug-resistant isolates of Pseudomonas aeruginosa from two outbreaks in UK hospitals were characterized by whole
genome sequencing (WGS). Although these isolates were resistant to antibiotics other than colistin, we conﬁrmed that they are still
sensitive to disinfectants. The sequencing conﬁrmed that isolates in the larger outbreak were serotype O12, and also revealed that they
belonged to sequence type ST111, which is a major epidemic strain of P. aeruginosa throughout Europe. As this is the ﬁrst reported
sequence of an ST111 strain, the genome was examined in depth, focusing particularly on antibiotic resistance and potential virulence genes,
and on the reported regions of genome plasticity. High degrees of sequence similarity were discovered between outbreak isolates collected
from recently infected patients, isolates from sinks, an isolate from the sewer, and a historical isolate, suggesting that the ST111 strain has
been endemic in the hospital for many years. The ability to translate easily from outbreak investigation to detailed genome biology by use of
the same data demonstrates the ﬂexibility of WGS application in a clinical setting.
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An outbreak investigation into the spread of multidrug-resis-
tant Pseudomonas aeruginosa susceptible only to colistin, in two
UK hospitals, was previously described [1]. Recent guidelines
redeﬁne these isolates as extensively drug-resistant (XDR) [2],
owing to susceptibility to only one class of antibiotic (colistin).
The outbreaks occurred in university teaching hospitals in the
south of England: one in London (outbreak 1), and one on the
south coast (outbreak 2). In outbreak 1, 85 hospital-wide
cases were identiﬁed between 2005 and 2011, and during
outbreak 2, four cases occurred in a single ward between 2009
and 2010. An environmental investigation was conducted to
identify potential sources of infection and inform control
measures that might reduce spread.
Outbreak 1 consisted of sporadic outbreaks separated by
long infection-free periods. This outbreak was caused by a
serotype O12 strain that caused severe infection, usually in
immunocompromised patients. As reported previously [1], the
overall case-fatality during outbreak 1 was 34/85 (40%); in
patients with bacteraemia, the case-fatality was as high as 14/18
(78%). Haematology patients were more likely to have
bacteraemia (six of seven cases). During outbreak 2, all cases
had bacteraemia, and there were no deaths attributed to XDR
P. aeruginosa. The potential of waste water systems to act as a
reservoir for XDR P. aeruginosa was reported in both
outbreaks.
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At the time, the UK reference laboratory reported that
compared to the national database, there were no identical
strains from elsewhere to the strain associated with the
outbreak 1 type using Variable Number Tandem Repeat
(VNTR) analysis [3]. However, genome sequencing revealed
that the outbreak strain belonged to sequence type ST111,
one of a small number of major epidemic clones that are
widespread in Europe, and that, for example was recently
reported as the major metallo-b-lactamase-producing P. aeru-
ginosa clone in The Netherlands [4]. We describe the clinical
application of whole genome sequencing (WGS) in these two
hospital outbreaks to discover the relationships between
circulating patient and environmental strains that may inform
infection control measures. Furthermore, greater understand-
ing of the biology of the XDR strain gained from the genome
sequence may provide useful insights into the pathogenicity,
and guide future treatment or disinfectant decisions.
To our knowledge, this is the ﬁrst report of a genome
sequence of an ST111 or an XDR strain of P. aeruginosa. We
describe mutations and elements associated with antibiotic
resistance, and compare the genome sequence with a collec-
tion of clinical and environmental isolates from both outbreaks
and other published genomes.
Materials and Methods
Susceptibility testing, serotyping, pulsed-ﬁeld gel
electrophoresis (PFGE), and VNTR
Serotyping, PFGE and VNTR typing were performed by the
Health Protection Agency, Colindale, UK (now the Public
Health England, Laboratory for Healthcare Associated Infec-
tion). Susceptibility testing with BSAC disk diffusion methods
has been described previously [1].
Susceptibility to various disinfectants/antiseptics was deter-
mined with standard methods [33] for P. aeruginosa, by
measuring the MIC. The test strain for assessing the bacteri-
cidal efﬁcacy of disinfectants, strain NCTC6749 was included.
Each disinfectant was serially diluted by doubling dilutions.
Three replicates were performed at each dilution, and the
modal value was taken.
Isolate preparation and DNA preparation
Isolates were obtained from several environmental and patient
sources (Table 1). The sewer sample was isolated according
to Moore et al. [34]. Brieﬂy, a gauze swab was placed in a
sewer outlet pipe fed from three buildings on the hospital site
for 48 h. Fragments of the swab were incubated in selective
broth (Nutrient Broth; Oxoid, Basingstoke, UK) containing
5 mg/mL vancomycin and 10 mg/mL meropenem overnight at
37°C, and this was followed by single-colony selection and
overnight growth on Columbia blood agar plates (Oxoid).
Single colonies were selected, and species were veriﬁed with
API NE (BioMerieux, Marcy l’Etoile, France).
Isolates were incubated overnight under aerobic conditions
at 37°C on Columbia blood agar plates. Single colonies were
subsequently grown for a second time overnight under the
same conditions before DNA extraction with the FastDNA
SPIN Kit for soil (MP Biomedicals, Santa Ana, CA, USA).
DNA sequencing
WGS was performed with the Ion Torrent Personal Genome
Machine (Life Technologies, Paisley, UK). Five micrograms of
genomic DNA was fragmented by sonication with a BioRupter
UD-200, and the library was prepared with the Ion Fragment
Library Kit (Life Technologies), according to the manufac-
turer’s instructions. Brieﬂy, fragmented DNA was
end-repaired, ligated to ion-compatible adapters, size-selected
for optimum insert length, and then nick-translated and
ampliﬁed. Size selection was carried out with a 2% E-Gel
SizeSelect Agarose Gel (Invitrogen, Paisley, UK) to produce a
library with a median fragment size of c. 200 bp. The DNA
library was clonally ampliﬁed on Ion Sphere Particles by
emulsion PCR with the Ion Xpress Template kit, and
sequenced on an Ion 316 chip with the Ion Sequencing Kit
v 2.0, which generates an average read length of c. 100 bp.
TABLE 1. Pseudomonas isolates sequenced in this study
Strain name Sourcea Date VNTR type Serotype MLSTb MLST proﬁlec
1 PA38182 Patient A, bloodd 14 February 2011 11, 3, 4, 3, 2, 2, 5, 4, 7 O12 ST111 17,5,5,4,4,4,3
2 PA48922 Patient A, sinkd 1 March 2011 11, 3, 4+, 3, 2, 2, , 4, 7 O12b ST111 17,5,5,4,4,4,3
3 PP48922 Patient A, sinkd 1 March 2011 NA (Pseudomonas putida) NA NA
4 PA46218 Patient A, sinkd 21 February 2011 11, 3, 4+, 3, 2, 2, 5, 4, 11 O12b ST111 17,5,5,4,4,4,3
5 PASwab Sewerd 6 October 2011 11, 3, 4, 3, 2, 2, 5, 4, 7 O12b ST111 17,5,5,4,4,4,3
6 PA128572 Patient B, bloodd 12 August 2006 11, 3, 4, 3, 2, 2, 5, 4, 7 O12b ST111 17,5,5,4,4,4,3
7 PA99736 Patient C, bloodd 2 May 2011 11, 4, 5, 2, 3, 2, , 4, 12 O6b ST155 28,5,36,3,3,13,7
8 PA97498 Patient, bloode 2 August 2010 11, 3, 2, , 3, 1, 9, 3, 10 f ST654 17,5,26,3,4,4,26
9 PA156066 Patient, bathroome 4 May 2011 11, 3, 2, , 3, 1, 9, 3, 10 f ST654 17,5,26,3,4,4,26
MLST, multilocus sequence typing; NA, not applicable; ST, sequence type; VNTR, variable-number tandem-repeat. aSee section Isolate phenotyping for isolate descriptions.
bInferred from sequence data. cMLST genes are: acs, aro, gua, mut, nuo, pps, and trp. dHospital 1. eHospital 2. fUndeterminable from sequence data.
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Sequence analysis
Sequence quality was assessed with Fastqc (http://www.bioin-
formatics.babraham.ac.uk/projects/fastqc/). Reads were
trimmed to a maximum length of 150 bp with seqtk (https://
github.com/lh3/seqtk). Sequence assembly was performed with
MIRA v3.9.4 [35], with default parameters for Ion Torrent data.
Automated gene annotation was performed with Prokka v1.6
(http://www.vicbioinformatics.com/software.prokka.shtml).
Manual analysis and sequence inspection were performed with
the Artemis and ACT genome visualization tools [36,37].
In silico serotype and multilocus sequence typing (MLST)
analyses
The serotype was inferred in silico by similarity searching a
database of O-antigen gene sequences of serotypes O1–O20
with BLASTN [38] (Genbank accessions: AC104719,
AC104720, AC104721, AC104722, AC104723, AC104724,
AC104725, AC104726, AC104727, AC104728, AC104729,
AC104730, AC104731, AC104732, AC104733, AC104734,
AC104735, AC104736, AC104737, AC104738, and
AC104739). MLST types were determined with a method
involving mapping reads to the PAO1 reference genome
(RefSeq: NC_002516), and subsequent BLAST comparison of
consensus sequences with the P. aeruginosa MLST database.
Phylogenetic analysis
Whole genome phylogenetic reconstruction was performed as
previously described [39]; genomes were aligned with Mugsy
[40], core genome sequences were extracted with mothur [41],
and maximum-likelihood inference was performed with RAx-
ML v7.4.2 [42], with aGTRmodel of nucleotide substitution and
a GAMMA model of rate heterogeneity; branch support values
were determined with 1000 bootstrap replicates.
Single-nucleotide polymorphism (SNP)-based phylogenetic
reconstruction was performed with a method similar to that in
[22]. Brieﬂy, reads were mapped to the LESB58 reference
genome (RefSeq: NC_011770; [43]) with TMAP v3.4.0 (Life
Technologies, Paisley, UK), and alignments were sorted with
Picard v1.76 (http://picard.sourceforge.net/). Per-base align-
ment statistics were generated with samtools mpileup
(v0.1.18) [44], and variants were called with bcftools v0.1.17-
dev. Variant sites were ﬁltered according to the following
criteria: mapping quality above 30, site quality score above 30, at
least four reads covering each site, with at least two reads
mapping to each strand butwith amaximumdepthof coverageof
200, at least 75% of reads supporting the site (DP4), and allelic
frequency (AF1) of 1. Sites that failed tomeet these criteria in any
strainwere removed from the analysis.Also, sites corresponding
to known phage or genomic islandswere removed. Phylogenetic
reconstruction was performed with RAxML v7.4.2 [42] as
above, and branch SNP counts were estimated by ancestral
sequence reconstruction performed with PAML v4 [45].
Results
Isolate phenotyping
All isolates of P. aeruginosa that were collected from out-
break 1 from June 2005 onwards were resistant to carbapen-
ems. These isolates were sent for typing at a reference
laboratory, and 74 of 85 were all reported as being
serotype O12, PCR-positive for the blaVIM-2 b-lactamase
gene, and identical or very similar by PFGE and/or VNTR
typing [1]. The other 11 isolates were all different, and the
cases from which they were obtained were deemed to be
unrelated sporadic cases caused by different resistant P. aeru-
ginosa strains. According to VNTR typing, a small number of
these were single-locus variants, which we considered to
probably be the same strain with minor sequence variations
leading to a single-locus variant. The reference laboratory also
reported this VNTR type as being unique to this hospital.
In order to characterize this strain type, PA38182 (desig-
nated as the primary isolate because it was from a current
patient (patient A)), as well as eight control samples, were
examined further (Table 1).
 Four environmental isolates from outbreak 1 were included:
two P. aeruginosa isolates (PA48922 and PA46218) from
patient A’s sink (isolated 3 weeks apart), a Pseudomonas
putida isolate (PP48922) that was isolated at the same time
from the sink, as there is evidence that P. putida can act as a
reservoir of mobile elements for P. aeruginosa [5], and a
P. aeruginosa isolate obtained from the sewer with a Moore’s
swab (PASwab).
 One P. aeruginosa isolate (PA128572) of the same VNTR type
isolated fromapatient (patient B) in hospital 1 6 years earlier.
 One XDR P. aeruginosa isolate (PA99736) of a different
VNTR type from patient C at the same hospital.
 Two XDR P. aeruginosa isolates (PA97498 and PA156066)
from outbreak 2—one clinical and one environmental.
These isolates were characterized by VNTR (Table 1), and
MIC data for the outbreak 1 representative isolate PA38182
are shown in Table 2.
As these isolates were susceptible to only one class of
antibiotics, their susceptibility to disinfectants is critical for
infection control purposes. We therefore carried out tests
with a variety of disinfectants (Table 3). These showed that the
isolates from outbreak 1 were similar in sensitivity to a
susceptible control strain, with all being sensitive at practical
concentrations.
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Sequence analysis
WGS was carried out with an Ion Torrent Personal Genome
Machine generating between 0.5 and 2 million reads per
sample, with an average length of 120 bp. Sequence data were
analysed by both reference mapping and de novo assembly
approaches.
The genome sequence-inferred serotypes were determined
by BLAST comparison against publicly available O-antigen gene
sequences (see Materials and Methods). An identity of >99%
across the entire 25-kb O12 locus conﬁrmed the reference
laboratory’s designation of the index isolate (PA38182) as
serotype O12, in addition to all other isolates related to the
outbreak, including the 6-year-old isolate. The unrelated isolate
from hospital 1 (PA99736) was inferred to be serotype O6.
MLST has been used to type P. aeruginosa strains across the
world [6], and has the advantage of ease of data comparison
between studies. MLST on the genome sequence identiﬁed the
outbreak cluster isolates from hospital 1 as ST111, whereas
the VNTR-unrelated isolate (PA99736) was ST155, and the
two hospital 2 isolates were ST654 (Table 1).
Phylogenetic reconstruction
In order to determine epidemiological links between the
isolates, the phylogenetic relatedness of the isolates was
determined in two ways: core genome sequence alignment,
and SNP-based reconstruction. Whole genome phylogenetic
reconstruction was performed with the core genomes of the
isolates sequenced here in the context of 35 genomes available
in the public databases (Fig. 1a).
The ST111 and ST654 isolates were more related to each
other than to other sequences in the public databases;
however, the number of publicly available P. aeruginosa
genome sequences available is limited, and the strains are
diverse. The ST155 isolate clustered tightly with other ST155
strains from China. The previously sequenced serotype O12
strain (PA7) is a taxonomic outlier [7], and has signiﬁcantly
diverged from the ST111 O12 isolates sequenced in this study
(Fig. S1). Therefore, PA7 was removed from the tree, as was
an unpublished sequence similar to PA7, VRFPA01 (Genbank:
AOBK01000001.1), in order to aid visualization of the
remaining relationships.
In order to investigate further the relationships between the
ST111 isolates, SNP sites were identiﬁed with respect to a
reference sequence. Sites where all isolate sequences were
identical but differed only from the reference were ignored,
leaving only sites with variation between the isolates. Phylo-
genetic reconstruction of the ST111 outbreak isolates based
on 24 variant sites identiﬁed by mapping to the LESB58
reference genome (RefSeq: NC_011770; several reference
sequences were used independently, owing to the lack of a
previously sequenced ST111 reference, and showed a consis-
tent relationship (data not shown)), suggested that the sewer
isolate is very closely related to both the clinical and the
associated sink isolates collected (Fig. 1b). Also, the similarity
of the historical isolate (PA128572) suggests that this strain has
been present in the hospital for at least 6 years.
Genome analysis of XDR ST111 isolates
Sequence reads of the XDR ST111 isolates were both mapped
to other published sequences and assembled de novo. The
isolates were highly similar, but the invasive clinical isolate
PA38182 was used as the primary isolate for ST111 in the
sequence analysis. For this isolate, 460 contigs (>500 bp)
totalling 7 Mb were obtained, and no major deletions as
compared with the reference strains were identiﬁed, except
for those accessory elements detailed below. Despite ST111
being a global epidemic strain of P. aeruginosa, there is no
previously reported genome sequence of an ST111 strain.
TABLE 2. MICs of antibiotics for a representative isolate of
ST111 (isolate PA38182)











Penicillin/b-lactamase inhibitor Piperacillin–tazobactam 64
Polymyxin Colistin 2
Carboxypenicillin–b-lactamase inhibitor Ticaricillin–clavulanate 64
Tetracycline Minocycline 32
Glycylcycline Tigecycline 16
TABLE 3. MICs of disinfectants;
isolates PA38182, PA128572 and
PASwab were tested, and the stan-
dard test strain for assessing bacte-
ricidal efﬁcacy of disinfectants, strain
NCTC6749, was also included
Disinfectant Initial concentration
MIC obtained
NCTC6749 PA128572 PA38182 PASwab
Povidone iodine 10% 1 in 8 1 in 8 1 in 8 1 in 8
Chlorhexidine 4% 1 in 4 1 in 4 1 in 4 1 in 4
NaDCC 1000 p.p.m. 1 in 2 1 in 2 1 in 2 1 in 2
Glutaraldehyde 2% 1 in 8 1 in 8 1 in 8 1 in 4
Chlorine dioxide 1100 p.p.m. 1 in 8 1 in 8 1 in 16 1 in 16
Peracetic acid 1500 p.p.m. 1 in 32 1 in 32 1 in 64 1 in 64
Triclosan 1% 1 in 2 1 in 2 1 in 2 1 in 2
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Therefore, a detailed study of the PA38182 genome content
was conducted, focusing particularly on antibiotic resistance
and virulence elements.
Antibiotic resistance. The MICs in Table 2 show that ST111 is
clinically resistant to most antibiotics. Analysis of the genome
sequence of ST111 identiﬁed key genetic mutations and the
presence of multiple genes implicated in resistance to a wide
range of pharmaceutical agents.
Quinolones—Amino acid changes in the proteins encoded by
the gyrA (T83I) and parC (S87L) genes of ST111 are most likely
responsible for the resistance to the ﬂuoroquinolones, as
described previously [8].
*
[6yo strain] + 
[Patient A sink] + 
[Patient A sink] + 







FIG. 1. (a) Phylogenetic relationship
between Pseudomonas aeruginosa isolates
sequenced in this study in the context of 35
genome sequences from public databases
(seeTable S2 foraccessions), basedoncore
genome alignments. Sequence-derived
MLST type is included in square brackets.
PA7 was excluded as an outlier. (1)
Outbreak 1 strains. (2) Outbreak 2
strains. (3) Unrelated strain from
hospital 1. (b) Phylogenetic reconstruction
from 24 ST111-speciﬁc variant sites
identiﬁed by comparing isolate read data
with thereferencegenomeLESB58(RefSeq:
NC_011770). The tree is rooted to
NC_011770. Asterisks mark branches
with 100% bootstrap support values.
Ancestral site reconstruction was used to
estimate the number of single-nucleotide
polymorphism (SNP) changes on branches;
brancheswith signiﬁcant support values are
labelled with the estimated number of
SNPs out of the total number of SNP
sites identiﬁed when mapped against
LESB58, PAO1, and UCBPP-PA14 (RefSeq:
NC_011770,NC_002516,andNC_008463),
respectively. The scale bar indicates
estimated mutations per site.  refers to
presence/absence of putative phage (see
Fig. 2). See section Isolate phenotyping for
isolate descriptions.
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Aminoglycosides—Several aminoglycoside resistance-encoding
genes were identiﬁed; ST111 contains the aacA29a
and aacA29b genes (aminoglycoside-6′-N-acetyltransferase),
most likely surrounding the blaVIM-2 gene, as described previ-
ously [9]. Also, an aminoglycoside phosphotransferase (aph)-IIb
gene, a FadE36 aph gene and a further putative aph gene were
identiﬁed. ST654 did not contain the aacA29a and aacA29b,
genes but did contain copies of the same aph genes as ST111;
furthermore, it also contained an ant(4′)-IIb gene, and two genes
annotated as associated with streptomycin resistance. ST155
had limited speciﬁc aminoglycoside-speciﬁc genes, containing
copies of only the aph-IIb gene and the putative aph gene
described above.
b-Lactamases—The ubiquitous class C b-lactamase gene ampC
showed no apparent mutations, and neither did ampG. How-
ever,mutations in the ampC regulator genes, ampD (G148A) and
ampR (E283G),were present, but it is not knownwhat role these
may play. Class B metallo-b-lactamase (MBL) genes, providing
resistance to b-lactams except monobactams, are commonly
located on mobile elements. ST111 isolates in Norway and
Sweden were reported to have both the blaVIM-2 MBL gene and
associated aminoglycoside acetyltransferase genes (aacA29a/
aacA29b) on a single cassette [9]; our ST111 isolate contained
the same genes, but we were unable to deduce the arrangement
from the assembly, probbaly because of the high level of identity
between aacA29a and aacA29b ﬂanking the blaVIM-2 gene, causing
contig breaks either side of the blaVIM-2 gene.
The ST654 isolates described in [9] had a cassette carrying the
blaVIM-2 MBL gene, the strA and strB streptomycin resistance
genes, and the aadB gene but no aacA29a or aacA29b genes. This
is consistentwith our ST654 sequence, except that no aadB gene
was found, suggesting a variant in this isolate.
Efﬂux pumps—Efﬂux pumps are potentially responsible for
resistance to a wide range of agents in P. aeruginosa, and,
indeed, the ST111 isolate contained copies of the mexAB–
oprM, mexCD–oprJ, mexEF–oprN, mexHI–opmD operons and
their respective regulator genes mexR, nfxB, mexT, and mexG.
Additionally mexMN, mexVW and mexXY sequences were
identiﬁed.
More specialized efﬂux pumps were also identiﬁed. These
included the triABC [10] and mexJKL operons [11], which have
been shown to be associated with triclosan resistance, and the
czcCBA operon, which has been shown to confer heavy metal
resistance [12]. These appeared to be contained within
integrated phages or integrons. Additionally, the cop-
per-induced mexPQ–opmE efﬂux pump gene [13] was present.
Other P. aeruginosa efﬂux system genes identiﬁed were
muxABC–opmB [14], emrAB–opmG [15] and a gene encoding
the small multidrug resistance family of proteins, which that
confer resistance to a wide variety of quaternary ammonium
compounds through a proton–drug efﬂux antiport mechanism.
Colistin—All of these isolates are currently sensitive to colistin
(polymyxin E). Initial studies on the genetic basis of colistin
resistance have implicated the two-component system pmrAB
and phoPQ genes in P. aeruginosa, Salmonella enterica serovar
Typhimurium, and Acinetobacter baumannii [16–18], presumably
by altering expression of the genes that are directly respon-
sible. Our studies conﬁrmed a lack of alterations in either the
pmrAB gene or phoPQ gene in the isolates studied here.
Virulence factors. Comparison with the Virulence Factor Data-
base (http://www.mgc.ac.cn/VFs/) shows that most of the
common virulence factors are present in the ST111 isolates
studied here. Notably, the gene for the type III secretion
system equivalent to the PA1690–PA1725 locus in PAO1 is
present, along with the genes for the effectors, exoenzymes
ExoS and ExoT and adenylate cyclase ExoY (ST654 carries the
same effectors, but ST155 is missing the exoY gene). The ST111
ExoS protein has an S121N change relative to published
sequences. The type IV pilus biosynthesis cluster is present, as
is the associated twitching motility protein locus.
The ST111 accessory genome. Studies of the P. aeruginosa
genome have shown it to have a conserved core genome, with
variable regions scattered throughout. These regions have been
referred to as regions of genome plasticity (RGPs) [19] by
including ‘any region of at least four contiguous ORFs that are
missing in at least one of the genomes analyzed’. Whereas some
of these RGPs appear to be sites where deletions rarely occur,
others appear to be sites where frequent changes occur,
through additions and losses within the region, or through
replacement of the entire region. Some of the genes or sets of
genes can be potential virulence genes, and include phages,
integrons carrying genes encoding type IV secretion systems,
genes encoding resistance to heavy metals, organic solvents, or
acriﬂavine, or genes encoding efﬂux pumps.
Table S1 includes a detailed analysis of the accessory
genome in isolate PA38182. Several accessory elements
appeared to be novel to P. aeruginosa, as shown by BLAST
similarity with the non-redundant database at NCBI:
 RGP2 contains an araC family regulator gene as part of an
c. 5-kb region that has no BLAST hits to any P. aeruginosa
sequences in NCBI’s non-redundant database, but shows
98% similarity to the P. putida genome sequenced in this
study.
ª2014 The Authors
Clinical Microbiology and Infection ª2014 European Society of Clinical Microbiology and Infectious Diseases, CMI, 20, O609–O618
O614 Clinical Microbiology and Infection, Volume 20 Number 10, October 2014 CMI
 RGP5 contains an integrated conjugative element including a
type II secretion system gene and a DNA topoisomerase III
gene, both of which are also novel to P. aeruginosa.
 Other integrated conjugative elements containing Trb
conjugal protein loci were also found in RGP26, RGP36,
and RGP75, the latter two also containing the copG gene,
which encodes a putative metal-transporting P-type AT-
Pase, thought to confer copper resistance [20]. Further-
more, the element contained within RGP75 has been
sequenced in P. aeruginosa strain NCGM2.S1 previously, as
well as having 99% identity with the P. putida sequenced in
this study.
 Other examples of accessory elements carrying resistance
genes can be seen in RGP29, where a phage-like element
contains the gene encoding the czcCBA heavy metal efﬂux
pump system, and in RGP56, which contains the gene
encoding the putative multidrug-efﬂux transporter, which is
also equivalent to PLES_22791 in LESB58.
 A type IV pilus operon is present in RGP41, and has a high
level of similarity to that found in RGP7 of PA7 [7].
 RGP42 is the site for another novel phage, this containing a
zona occludens toxin gene that is highly similar to PA0726,
found in RGP5 of PAO1.
 On comparison with previously described genomic islands,
evidence of complete or remnant PAGI-7 (RGP88), PAGI-8
(RGP86) and PAGI-9 (RGP89) sequences was also seen
[21].
All of the ST111 isolates sequenced in this study carried
the same accessory components, except for the presence of
a phage in RGP87, which was variably present in the isolates;
only the historical clinical isolate PA128572 and the
recent environmental isolates PA48922 and PA46218
contained the phage (Fig. 2). However, no obvious pheno-
typic association with the presence of this phage could be
identiﬁed.
Discussion
WGS has been demonstrated to be a very powerful tool in
diagnostic microbiology [22–24], with the potential to provide
results in a clinically relevant time frame. This is especially true
for epidemiological typing, which can guide infection control
investigation of outbreaks. In this study, WGS was applied to a
selection of isolates of P. aeruginosa that were collected during
an investigation into two hospital outbreaks [1]. We have
shown that, in these outbreaks, the environmental and patient
isolates of P. aeruginosa that caused signiﬁcant morbidity are
highly related within each hospital. This provides further
evidence for the potential of the waste water system to act as
a reservoir for infection.
Identiﬁcation of ST111
The isolates from outbreak 1 had previously been shown to be
closely related by VNTR typing, and were thought to be
speciﬁc to the hospital in which the outbreak occurred.
However, WGS analysis showed that the strain belongs to the
global epidemic type ST111, which is thought to be responsible
for many of the multidrug-resistant P. aeruginosa cases around
the world [4,9].
We report the ﬁrst full genome sequence of an ST111
strain. ST111 isolates have been identiﬁed in the UK previously
by MLST [25]; however, MLST is not routinely performed on
incoming isolates by the UK reference laboratory. This
demonstrates that VNTR typing has limited utility in isolation
without comparison with MLST, and that sequence-based
typing schemes must be adopted for use in tandem with or to
replace VNTR typing.
Sequencing of selected genes from PA7, which is also
serotype O12, has previously shown that it is signiﬁcantly
divergent from the worldwide multidrug-resistant O12 clone







FIG. 2. Read coverage across differential
phage regions within ST111 isolates. (a)
Predicted genes; putative phage genes are
coloured red. (b) PA128572. (c) PA48922.
(d)PA46218. (e) PA38182. (f) PASwab.
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provides more complete genomic evidence of how dissimilar
these two O12 strain types are.
Water colonization
Blockages account for the most signiﬁcant contamination of
clinical areas from the waste water system [1]. Therefore, the
implication of the waste water system as the source of the
XDR P. aeruginosa in 2011 led to the implementation of many
control measures in hospital 1 to reduce contamination of
clinical areas from blockages, leaks, and splashback events [1].
Subsequently, only infrequent XDR P. aeruginosa colonization
events and clinical infections have occurred in both immuno-
compromised and non-immunocompromised individuals asso-
ciated with the main hospital wing.
Indeed, since April 2012, there have been only four
P. aeruginosa ST111 clinical infections in patients who have
spent time on the general intensive-care unit, consisting of two
infections in 2012 and two infections in 2013. On both
occasions, ST111 strains were isolated simultaneously from
the sink U-bends and basins in patient rooms and from the
sluice room.
The fact that we recently recovered from the sewer an isolate
of ST111 that is highly related to current patient and environ-
mental isolates and a historical patient isolate is further evidence
that the waste water system probably acts as a reservoir for
nosocomial transmission of XDR P. aeruginosa in this hospital.
However, sequencing of other ST111 isolates from a separate
source would give us a much greater understanding of the level
of diversity within this strain population. The recurring nature of
these infections over a lengthy period of time suggests that this is
more likely than transfer of XDR P. aeruginosa from colonized
patients to thewaste water system. Furthermore, consideration
must be given to the downstream environmental impact of
drug-resistant P. aeruginosa, which has been shown to be
present in waste water treatment plants downstream of
hospitals elsewhere [27].
The ST111 genome
In addition to the epidemiological information generated by
WGS, genetic markers of drug resistance and virulence can be
identiﬁed and potentially used to guide better treatment
decisions for clinical case management. Speciﬁc genetic mark-
ers for ﬂuoroquinolone, aminoglycoside and b-lactam resis-
tance were identiﬁed in our study; indeed, Akasaka et al. [28]
suggested that the pattern of gyrA mutations identiﬁed in our
ST111 isolates would confer susceptibility to the ﬂuoroquino-
lone sitoﬂoxacin, but we were unable to obtain this drug for
testing. Indeed, rapid genotyping for these SNPs across these
speciﬁc gyrA regions could be a useful clinical indicator for
antibiotic choice.
Thewide-ranging speciﬁcities of the efﬂux pumpmachinery in
P. aeruginosa are striking, butmake full antibiotic and disinfectant
genotype to phenotype predictions much more complicated,
requiring more experimental information on the regulation of
these operons and the speciﬁcities of their receptor molecules.
Transcriptional regulation of these pumps would probably
explain the susceptibility to disinfectants such as triclosan,
despite the presence of pumps associated with resistance. In
addition to the efﬂux pumps, the presence of genes responsible
for copper resistance, heavy metal resistance and acriﬂavine
resistance shows that this organism is heavily adapted to live in
harsh environmental conditions such as waste water systems.
Phage integration appears to be important for the carriage of
some of these elements and, indeed, metagenomic studies have
previously shown the presence of various phage-related resis-
tance markers in activated sludge from waste water treatment
plants [29]. The presence of a phage in some but not all of the
ST111 isolates is difﬁcult to interpret, owing to the small number
of isolates sequenced; it may simply reﬂect the transient nature
of phages within these genomes, or may be attributable to phage
loss in the isolation process.
One P. putida isolate was sequenced out of curiosity,
because there has been speculation that this species could
act as a reservoir for horizontal gene transfer. One element
was identiﬁed within RGP2 of PA38182 with a high level of
nucleotide similarity (98%) to the P. putida genome; this
sequence has been seen in other sequenced genomes of
P. putida, but not in other P. aeruginosa sequences within the
public databases, suggesting that this element may have been
transferred within the context of this outbreak, but may
equally just have transferred between species in the past, the
parent strains of P. aeruginosa containing not having yet been
identiﬁed and sequenced. A second element with high levels of
similarity to the P. putida sequence was identiﬁed within
RGP75 of PA38182, but this has been previously found in both
P. putida and P. aeruginosa sequences in the public databases,
suggesting that any transfer between species may have
occurred previously.
In this study, isolates from two separate UK hospital
outbreaks were sequenced and compared, in order to identify
any genetic evidence for the difference in mortality rates;
however, within known virulence elements, only the S121N
change in ExoS could be found, a site identiﬁed previously in an
investigation of ExoS virulence, but its role could not be
conclusively determined [30].
The P. aeruginosa isolates studied here have all been shown
to be XDR and sensitive to only one antibiotic, colistin, in
addition to disinfectant agents. However, colistin resistance
has been described in patients with cystic ﬁbrosis [31,32], so it
is essential to monitor this organism carefully and to clinically
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manage treatment appropriately. Development of further
resistance would result in an organism that is refractory to
antibiotic treatment within the hospital, and could also lead to
loss of susceptibility to disinfectants, making infection control
and environmental management within the hospital difﬁcult.
We believe that routine WGS of all isolates within a hospital
environment would deﬁne the gene pool for resistance,
enabling both rapid molecular epidemiological investigation of
outbreaks and surveillance for antibiotic resistance, thus
informing good antibiotic stewardship—a major international
governmental imperative.
Sequence Data
Sequence data have been deposited in the European Nucle-
otide Archive with study accession number PRJEB4573.
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